Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib vs imatinib in chronic myeloid leukemia (Japan, phase 3)
jRCT2080220468Phase 3Completed
- Start
- Nov 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of nilotinib in chronic myelogenous leukemia (CML) (2 arms). Started Nov 2007; status: completed.
02
Drugs
nilotinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on jRCT2080220468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220468.